Veterinary Medicines

LEVOPLIX 300 mg, comprimate

Authorised
  • Levamisole hydrochloride
Download as PDF

Product identification

Medicine name:
LEVOPLIX 300 mg, comprimate
Active substance:
  • Levamisole hydrochloride
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    300.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        28
        day
    • Sheep
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Erfar S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Erfar S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 160177
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 24/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."